Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bone Disorders01:29

Bone Disorders

5.0K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
5.0K
Metastasis02:30

Metastasis

6.3K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.3K
What is the Skeletal System?01:02

What is the Skeletal System?

56.2K
Overview
56.2K
Bone Remodeling01:40

Bone Remodeling

40.0K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
40.0K
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

3.7K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clear cell chondrosarcoma: Cytologic findings in six cases.

Diagnostic cytopathology·2013
See all related articles

Related Experiment Video

Updated: Dec 17, 2025

Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone
06:53

Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone

Published on: September 9, 2020

3.1K

Bone Tumors: Metastatic Bone Disease.

Robert Esther1

  • 1UNC Orthopaedics, 130 Mason Farm Road CB# 7055, Chapel Hill, NC 27599-7055.

FP Essentials
|June 24, 2020
PubMed
Summary
This summary is machine-generated.

Metastatic bone disease affects millions, causing bone pain and fracture risks. Early diagnosis and multidisciplinary treatment, including bone-modifying agents, are crucial for managing this common cancer complication.

More Related Videos

Models of Bone Metastasis
08:49

Models of Bone Metastasis

Published on: September 4, 2012

42.8K
Intra-Cardiac Injection of Human Prostate Cancer Cells to Create a Bone Metastasis Xenograft Mouse Model
06:32

Intra-Cardiac Injection of Human Prostate Cancer Cells to Create a Bone Metastasis Xenograft Mouse Model

Published on: November 4, 2022

6.3K

Related Experiment Videos

Last Updated: Dec 17, 2025

Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone
06:53

Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone

Published on: September 9, 2020

3.1K
Models of Bone Metastasis
08:49

Models of Bone Metastasis

Published on: September 4, 2012

42.8K
Intra-Cardiac Injection of Human Prostate Cancer Cells to Create a Bone Metastasis Xenograft Mouse Model
06:32

Intra-Cardiac Injection of Human Prostate Cancer Cells to Create a Bone Metastasis Xenograft Mouse Model

Published on: November 4, 2022

6.3K

Area of Science:

  • Oncology
  • Orthopedics
  • Radiology

Background:

  • Metastatic bone disease is a frequent complication of cancer, impacting over 5 million people in the US.
  • Patients often present with bone pain, and the primary cancer may be unknown.
  • Bone metastases can be detected incidentally on imaging studies.

Purpose of the Study:

  • To review the common causes, diagnostic approaches, and management strategies for metastatic bone disease.
  • To highlight the importance of early detection and prevention of skeletal-related events.

Main Methods:

  • Review of clinical presentation, diagnostic imaging (X-ray, MRI, CT, nuclear medicine), and biopsy confirmation.
  • Discussion of preventative measures for pathologic fractures and current treatment modalities.
  • Consideration of bone-modifying agents (bisphosphonates, denosumab) and palliative care.

Main Results:

  • Metastatic bone disease requires a high index of suspicion in patients with cancer history or unexplained bone pain.
  • Multimodal imaging and biopsy are essential for diagnosis and staging.
  • Prevention of fractures and appropriate cancer-directed therapies are key management goals.

Conclusions:

  • Effective management of metastatic bone disease involves a comprehensive approach including pain control, fracture prevention, and systemic cancer treatment.
  • Bone-modifying agents play a significant role in improving bone health and reducing skeletal morbidity.
  • Multidisciplinary care, including palliative support, is vital for optimizing patient outcomes.